Hans Garmo

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 297-300, 2026

• DOI för Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Ladda ner fulltext (pdf) av Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 282-288, 2026

• DOI för Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Westerberg, Marcus; Gedeborg, Rolf; Garmo, Hans; Jäderling, Fredrik et al.

Ingår i BJUI Compass, 2026

• DOI för Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis
• Ladda ner fulltext (pdf) av Comparison of software vs. cognitive-based fusion-targeted biopsies for prostate cancer diagnosis

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Ingår i European Urology Open Science, s. 72-76, 2026

• DOI för Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Ladda ner fulltext (pdf) av Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Scilipoti, Pietro; Callenmark, Max; Garmo, Hans; Stattin, Pär et al.

Ingår i European Urology Open Science, s. 1-9, 2026

• DOI för Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy
• Ladda ner fulltext (pdf) av Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 297-300, 2026

• DOI för Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Ladda ner fulltext (pdf) av Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Acta Oncologica, s. 282-288, 2026

• DOI för Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study

Söderberg, Emma; Wärnberg, Fredrik; Wennstig, Anna-Karin; Nilsson, Greger et al.

Ingår i BJS, 2026

• DOI för Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study
• Ladda ner fulltext (pdf) av Comparing multifocal with unifocal breast cancer and the relationship with survival: national cohort study

Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Ventimiglia, Eugenio; Westerberg, Marcus; Zaurito, Paolo; Miranda, Tiago Bonde et al.

Ingår i Scandinavian journal of urology, s. 22-28, 2026

• DOI för Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer
• Ladda ner fulltext (pdf) av Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Ingår i Scandinavian journal of urology, s. 51-57, 2026

• DOI för Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Ladda ner fulltext (pdf) av Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Ventimiglia, Eugenio; Gedeborg, Rolf; Westerberg, Marcus; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 64-71, 2026

• DOI för Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results
• Ladda ner fulltext (pdf) av Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results

Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Lin, E.; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Ingår i International Journal of Cancer, s. 977-983, 2026

• DOI för Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons
• Ladda ner fulltext (pdf) av Prostate cancer characteristics in fathers and risk of early onset high-risk prostate cancer in sons

Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Zaurito, Paolo; Westerberg, Marcus; Garmo, Hans; Gedeborg, Rolf et al.

Ingår i BJU International, s. 103-111, 2026

• DOI för Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score
• Ladda ner fulltext (pdf) av Urinary tract events after radical radiotherapy (RT) for prostate cancer according to pre-RT International Prostate Symptom Score

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJU International, s. 629-638, 2026

• DOI för Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Persson, Astrid E.; Kjellén, Elisabeth; Garmo, Hans; Adrian, Gabriel et al.

Ingår i Radiotherapy and Oncology, 2026

• DOI för Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
• Ladda ner fulltext (pdf) av Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC

Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Hawez, Lewar; Bergengren, Oskar; Ahlberg, Mats; Garmo, Hans et al.

Ingår i Scandinavian journal of urology, s. 204-208, 2025

• DOI för Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden
• Ladda ner fulltext (pdf) av Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study

Alverbratt, Charlotte; Sandin, Fredrik; Kolmbäck, Viktor; Garmo, Hans et al.

Ingår i Acta Oncologica, s. 1391-1403, 2025

• DOI för Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study
• Ladda ner fulltext (pdf) av Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study

A Modular Framework for Treatment Effect Estimation in Latent Subgroups

Lindhagen, Lars; Garmo, Hans; Östlund, Ollie

Ingår i Journal of Statistical Theory and Applications, s. 1064-1090, 2025

• DOI för A Modular Framework for Treatment Effect Estimation in Latent Subgroups
• Ladda ner fulltext (pdf) av A Modular Framework for Treatment Effect Estimation in Latent Subgroups

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i Scandinavian journal of urology, s. 93-96, 2025

• DOI för Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Ladda ner fulltext (pdf) av Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Ingår i Scandinavian journal of urology, s. 105-107, 2025

• DOI för A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Ladda ner fulltext (pdf) av A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Ingår i Journal of the National Cancer Institute, s. 1142-1150, 2025

• DOI för Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Ladda ner fulltext (pdf) av Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

George, G.; Axelson, A. B.; Decaestecker, K.; Garmo, H. et al.

Ingår i ESMO Real World Data and Digital Oncology, 2025

• DOI för Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium
• Ladda ner fulltext (pdf) av Investigation into the clinical features, treatment patterns, and survival of older men with prostate cancer in Sweden and Belgium

Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

George, G.; Enting, D.; Garmo, Hans; Stattin, Pär et al.

Ingår i ESMO Real World Data and Digital Oncology, 2025

• DOI för Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries
• Ladda ner fulltext (pdf) av Guidelines and variations in patterns of GnRH analogue use in castration-resistant prostate cancer across six countries

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Lin, E; Garmo, Hans; Beckmann, Kerri; Bratt, Ola et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1585-1592, 2025

• DOI för Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden
• Ladda ner fulltext (pdf) av Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Westerberg, Marcus; Garmo, Hans; Bonnedahl, Jesper; Eriksson, Marie Hjälm et al.

Ingår i Scientific Reports, 2025

• DOI för Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer
• Ladda ner fulltext (pdf) av Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancer

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Ingår i European Urology Open Science, s. 41-50, 2025

• DOI för Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Ladda ner fulltext (pdf) av Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Ingår i BJUI Compass, 2025

• DOI för Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Ladda ner fulltext (pdf) av Potential gains from radical treatment of men with prostate cancer according to life expectancy

Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Strömberg, Ulf; Bonander, Carl; Garmo, Hans; Lambe, Mats et al.

Ingår i Acta Oncologica, s. 677-684, 2025

• DOI för Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity
• Ladda ner fulltext (pdf) av Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity

Gleason scores provide more accurate prognostic information than grade groups

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Pathology, s. 293-296, 2025

• DOI för Gleason scores provide more accurate prognostic information than grade groups
• Ladda ner fulltext (pdf) av Gleason scores provide more accurate prognostic information than grade groups

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i The Journal of the National Comprehensive Cancer Network, 2025

• DOI för Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Ingår i International Journal of Epidemiology, 2025

• DOI för Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Ladda ner fulltext (pdf) av Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.

Holmberg, Lars; Garmo, H.; Andersson, Sven-Olov; Andrén, Ove et al.

Ingår i European Urology, s. 554-558, 2025

• DOI för Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.
• Ladda ner fulltext (pdf) av Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cancer.

Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Westerberg, Marcus; Garmo, H.; Ludvigsson, Jonas; Stattin, Pär et al.

Ingår i Clinical Epidemiology, s. 983-993, 2025

• DOI för Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden
• Ladda ner fulltext (pdf) av Discriminative Ability of the Charlson Comorbidity Index for Long-Term Mortality in a General Population: Nationwide, Population-Based Study of 10 Million Adults in Sweden

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Ahlberg, Mats Steinholtz; Garmo, Hans; Stattin, Pär; Gedeborg, Rolf et al.

Ingår i Scandinavian journal of urology, s. 63-69, 2024

• DOI för Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study
• Ladda ner fulltext (pdf) av Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Egevad, Lars; Micoli, Chiara; Samaratunga, Hemamali; Delahunt, Brett et al.

Ingår i European Urology Oncology, s. 213-221, 2024

• DOI för Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study
• Ladda ner fulltext (pdf) av Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study

Söderberg, Emma; Wärnberg, Fredrik; Wennstig, Anna-Karin; Nilsson, Greger et al.

Ingår i The Breast, 2024

• DOI för Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study
• Ladda ner fulltext (pdf) av Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study

Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Robinson, David et al.

Ingår i JAMA Network Open, 2024

• DOI för Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting
• Ladda ner fulltext (pdf) av Natural History of Nonmetastatic Prostate Cancer Managed With Watchful Waiting

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Ingår i Scandinavian journal of urology, s. 98-103, 2024

• DOI för Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Ladda ner fulltext (pdf) av Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Stattin, Pär; Fleming, Sarah; Lin, Xiwu; Lefresne, Florence et al.

Ingår i BJU International, s. 96-102, 2024

• DOI för Population-based study of disease trajectory after radical treatment for high-risk prostate cancer
• Ladda ner fulltext (pdf) av Population-based study of disease trajectory after radical treatment for high-risk prostate cancer

Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Holmberg, Lars; Skogmar, Sten; Garmo, Hans; Hagberg, Oskar et al.

Ingår i BJU International, s. 229-238, 2024

• DOI för Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
• Ladda ner fulltext (pdf) av Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Ingår i Journal of Clinical Epidemiology, 2024

• DOI för Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Ladda ner fulltext (pdf) av Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study

Rask, Gunilla; Wadsten, Charlotta; Acs, Balazs; Hartman, Johan et al.

Ingår i British Journal of Surgery, 2024

• DOI för Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study
• Ladda ner fulltext (pdf) av Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Holmberg, Lars; Garmo, Hans; Andersson, Swen-Olof; Andrén, Ove et al.

Ingår i New England Journal of Medicine, s. 1362-1364, 2024

• DOI för Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Ingår i European Urology Oncology, s. 605-613, 2024

• DOI för Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Egevad, Lars; Micoli, Chiara; Delahunt, Brett; Samaratunga, Hemamali et al.

Ingår i Virchows Archiv, s. 995-1003, 2024

• DOI för Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study
• Ladda ner fulltext (pdf) av Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Ingår i BJU International, s. 486-493, 2023

• DOI för Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Angiosarcoma in the breast: a population-based cohort from Sweden

Olander, Susanne; Wennstig, Anna-Karin; Garmo, Hans; Holmberg, Lars et al.

Ingår i British Journal of Surgery, s. 1850-1856, 2023

• DOI för Angiosarcoma in the breast: a population-based cohort from Sweden

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Ingår i Acta Oncologica, s. 1815-1821, 2023

• DOI för Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Ladda ner fulltext (pdf) av Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Ingår i JAMA Network Open, 2023

• DOI för Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Ingår i British Journal of Cancer, s. 814-824, 2023

• DOI för Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Ahlberg, Mats Steinholtz; Garmo, Hans; Holmberg, Lars; Bill-Axelson, Anna

Ingår i European Urology Open Science, s. 166-173, 2023

• DOI för Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
• Ladda ner fulltext (pdf) av Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Ingår i Scandinavian journal of urology, s. 93-100, 2023

• DOI för Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Ladda ner fulltext (pdf) av Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Ingår i JAMA Network Open, 2023

• DOI för Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Ladda ner fulltext (pdf) av Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Van Hemelrijck, Mieke; Ventimiglia, Eugenio; Robinson, David; Gedeborg, Rolf et al.

Ingår i BMC Medical Informatics and Decision Making, 2022

• DOI för Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males
• Ladda ner fulltext (pdf) av Population-based estimates of age and comorbidity specific life expectancy: a first application in Swedish males

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Balabanova, Yanina; Farahmand, Bahman; Stattin, Pär; Garmo, Hans et al.

Ingår i BMC Urology, 2022

• DOI för Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Balabanova, Yanina; Farahmand, Bahman; Garmo, Hans; Stattin, Pär et al.

Ingår i BMJ Open, 2022

• DOI för Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden

Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Lin, E.; Garmo, Hans; Van Hemelrijck, Mieke; Zethelius, Björn et al.

Ingår i JAMA Network Open, 2022

• DOI för Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes
• Ladda ner fulltext (pdf) av Association of Gonadotropin-Releasing Hormone Agonists for Prostate Cancer With Cardiovascular Disease Risk and Hypertension in Men With Diabetes

Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Gedeborg, Rolf; Loeb, Stacy; Styrke, Johan; Kiiski-Berggren, Ritva et al.

Ingår i International Journal of Cancer, s. 1925-1934, 2022

• DOI för Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
• Ladda ner fulltext (pdf) av Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Ingår i Acta Oncologica, s. 328-332, 2022

• DOI för Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Khoshkar, Yashar; Westerberg, Marcus; Adolfsson, Jan; Bill-Axelson, Anna et al.

Ingår i BJUI Compass, s. 173-183, 2022

• DOI för Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
• Ladda ner fulltext (pdf) av Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Ingår i PLOS ONE, 2022

• DOI för Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Ladda ner fulltext (pdf) av Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

Ahlberg, Mats Steinholtz; Garmo, Hans; Adami, Hans-Olov; Andren, Ove et al.

Ingår i BMJ Open, 2022

• DOI för Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
• Ladda ner fulltext (pdf) av Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Ingår i European Urology Open Science, s. 46-51, 2022

• DOI för Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Ladda ner fulltext (pdf) av Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Ventimiglia, Eugenio; Bill-Axelson, Anna; Bratt, Ola; Montorsi, Francesco et al.

Ingår i JAMA Network Open, 2022

• DOI för Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
• Ladda ner fulltext (pdf) av Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Ingår i Scandinavian journal of urology, s. 169-175, 2022

• DOI för Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Ladda ner fulltext (pdf) av Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops

Eriksson, John; Norlén, Olov; Ögren, M.; Garmo, Hans et al.

Ingår i Scandinavian Journal of Surgery, s. 44-50, 2021

• DOI för Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops

Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Thomsen, Frederik B; Garmo, Hans; Brasso, Klaus; Egevad, Lars et al.

Ingår i Journal of Surgical Oncology, s. 867-875, 2021

• DOI för Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study
• Ladda ner fulltext (pdf) av Temporal changes in cause-specific death in men with localised prostate cancer treated with radical prostatectomy: a population-based, nationwide study

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study

Santaolalla, Aida; Sollie, Sam; Rislan, Ali; Josephs, Debra H. et al.

Ingår i BMC Immunology, 2021

• DOI för Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
• Ladda ner fulltext (pdf) av Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study

Data Resource Profile: Breast Cancer Data Base Sweden 2.0 (BCBaSe 2.0)

Wadsten, Charlotta; Wennstig, Anna-Karin; Garmo, Hans; Lambe, Mats et al.

Ingår i International Journal of Epidemiology, s. 1770-1771f, 2021

• DOI för Data Resource Profile: Breast Cancer Data Base Sweden 2.0 (BCBaSe 2.0)

Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Fallara, Giuseppe; Alverbratt, Charlotte; Garmo, Hans; Vikman, Hanna et al.

Ingår i Acta Oncologica, s. 1589-1596, 2021

• DOI för Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden
• Ladda ner fulltext (pdf) av Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden

Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study

Wennstig, Anna-Karin; Wadsten, Charlotta; Garmo, Hans; Johansson, Mikael et al.

Ingår i npj Breast Cancer, 2021

• DOI för Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study
• Ladda ner fulltext (pdf) av Risk of primary lung cancer after adjuvant radiotherapy in breast cancer: a large population-based study

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans et al.

Ingår i PLOS ONE, 2021

• DOI för A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
• Ladda ner fulltext (pdf) av A drug comorbidity index to predict mortality in men with castration resistant prostate cancer

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Ingår i Statistics in Medicine, s. 1172-1188, 2021

• DOI för Simulation model of disease incidence driven by diagnostic activity
• Ladda ner fulltext (pdf) av Simulation model of disease incidence driven by diagnostic activity

An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Gedeborg, Rolf; Sund, Malin; Lambe, Mats; Plym, Anna et al.

Ingår i Epidemiology, s. 607-615, 2021

• DOI för An Aggregated Comorbidity Measure Based on History of Filled Drug Prescriptions: Development and Evaluation in Two Separate Cohorts

Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

George, Gincy; Vikman, Hanna; Gedeborg, Rolf; Franck Lissbrant, Ingela et al.

Ingår i Acta Oncologica, s. 459-465, 2021

• DOI för Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden

Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

Lundstrom, Karl-Johan; Garmo, Hans; Gedeborg, Rolf; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 221-226, 2021

• DOI för Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study

No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

Hailer, Nils P.; Garland, Anne; Gordon, Max; Karrholm, Johan et al.

Ingår i International Journal of Cancer, s. 76-83, 2020

• DOI för No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis
• Ladda ner fulltext (pdf) av No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis

Observational study on time on treatment with abiraterone and enzalutamide

Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco et al.

Ingår i PLOS ONE, 2020

• DOI för Observational study on time on treatment with abiraterone and enzalutamide
• Ladda ner fulltext (pdf) av Observational study on time on treatment with abiraterone and enzalutamide

Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Loeb, Stacy; Cazzaniga, Walter; Robinson, David; Garmo, Hans et al.

Ingår i Journal of Urology, s. 145-150, 2020

• DOI för Opioid Use after Radical Prostatectomy: Nationwide, Population Based Study in Sweden

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Ingår i Acta Oncologica, s. 106-111, 2020

• DOI för Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Ladda ner fulltext (pdf) av Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Changes in lifestyle among prostate cancer survivors: A nationwide population-based study

Bergengren, Oskar; Enblad, Anna Pia; Garmo, Hans; Bratt, Ola et al.

Ingår i Psycho-Oncology, s. 1713-1719, 2020

• DOI för Changes in lifestyle among prostate cancer survivors: A nationwide population-based study
• Ladda ner fulltext (pdf) av Changes in lifestyle among prostate cancer survivors: A nationwide population-based study

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Ingår i BJU International, s. 142-151, 2020

• DOI för Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Ladda ner fulltext (pdf) av Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Enblad, Anna Pia; Bergengren, Oskar; Andrén, Ove; Larsson, Anders et al.

Ingår i Scandinavian journal of urology, s. 376-381, 2020

• DOI för PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing
• Ladda ner fulltext (pdf) av PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing

Prescription-based prediction of baseline mortality risk among older men

Gedeborg, Rolf; Garmo, Hans; Robinson, David; Stattin, Pär

Ingår i PLOS ONE, 2020

• DOI för Prescription-based prediction of baseline mortality risk among older men
• Ladda ner fulltext (pdf) av Prescription-based prediction of baseline mortality risk among older men

5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Miranda, Tiago Bonde; Garmo, Hans; Stattin, Pär; Robinson, David

Ingår i Journal of Urology, s. 714-719, 2020

• DOI för 5 alpha-Reductase Inhibitors and Risk of Prostate Cancer Death

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

Essen, Anneli; Santaolalla, Aida; Garmo, Hans; Hammar, Niklas et al.

Ingår i Cancer Causes and Control, s. 603-615, 2019

• DOI för Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort
• Ladda ner fulltext (pdf) av Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort

Radical Surgery or Watchful Waiting in Prostate Cancer Reply

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans

Ingår i New England Journal of Medicine, s. 1084-1084, 2019

• DOI för Radical Surgery or Watchful Waiting in Prostate Cancer Reply

Androgen deprivation therapy for prostate cancer and risk of dementia

Robinson, David; Garmo, Hans; Van Hemelrijck, Mieke; Damber, Jan-Erik et al.

Ingår i BJU International, s. 87-92, 2019

• DOI för Androgen deprivation therapy for prostate cancer and risk of dementia
• Ladda ner fulltext (pdf) av Androgen deprivation therapy for prostate cancer and risk of dementia

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

Cazzaniga, Walter; Garmo, Hans; Robinson, David; Holmberg, Lars et al.

Ingår i BJU International, s. 421-428, 2019

• DOI för Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study

How to measure temporal changes in care pathways for chronic diseases using health care registry data

Ventimiglia, Eugenio; Van Hemelrijck, Mieke; Lindhagen, Lars; Stattin, Pär et al.

Ingår i BMC Medical Informatics and Decision Making, 2019

• DOI för How to measure temporal changes in care pathways for chronic diseases using health care registry data
• Ladda ner fulltext (pdf) av How to measure temporal changes in care pathways for chronic diseases using health care registry data

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Ahlberg, Mats Steinholtz; Adami, Hans-Olov; Beckmann, Kerri; Bertilsson, Helena et al.

Ingår i BMJ Open, 2019

• DOI för PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
• Ladda ner fulltext (pdf) av PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Thomsen, Frederik Birkebaek; Bosco, Cecilia; Garmo, Hans; Adolfsson, Jan et al.

Ingår i Acta Oncologica, s. 110-118, 2019

• DOI för Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study
• Ladda ner fulltext (pdf) av Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study

Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, C; Hellman, Per

Ingår i BJS Open, s. 345-352, 2018

• DOI för Prognostic factors for death after surgery for small intestinal neuroendocrine tumours
• Ladda ner fulltext (pdf) av Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

Birgegård, Gunnar; Folkvaljon, Folke; Garmo, Hans; Holmberg, Lars et al.

Ingår i Leukemia Research, s. 105-109, 2018

• DOI för Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Häggström, Christel; Van Hemelrijck, Mieke; Garmo, Hans; Robinson, David et al.

Ingår i International Journal of Cancer, s. 1868-1875, 2018

• DOI för Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus
• Ladda ner fulltext (pdf) av Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.

Ghoshal, Arunangshu; Garmo, Hans; Arthur, Rhonda; Carroll, Paul et al.

Ingår i Oncotarget, s. 774-782, 2018

• DOI för Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.
• Ladda ner fulltext (pdf) av Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.

Biomarkers in DCIS associated with breast cancer death

Wadsten, C.; Wärnberg, Fredrik; Tolockiene, E.; Hartman, J. et al.

Ingår i European Journal of Cancer, 2018

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Pettersson, A.; Robinson, D.; Garmo, Hans; Holmberg, Lars et al.

Ingår i Annals of Oncology, s. 2020-2021, 2018

• DOI för Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen

Radical Prostatectomy or Watchful Waiting in Prostate Cancer: 29-Year Follow-up

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans; Taari, Kimmo et al.

Ingår i New England Journal of Medicine, s. 2319-2329, 2018

• DOI för Radical Prostatectomy or Watchful Waiting in Prostate Cancer: 29-Year Follow-up

Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?

Ghoshal, Arunangshu; Garmo, Hans; Hammar, Niklas; Jungner, Ingmar et al.

Ingår i BMC Cancer, 2018

• DOI för Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
• Ladda ner fulltext (pdf) av Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?

Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Arthur, R.; Williams, R.; Garmo, Hans; Holmberg, Lars et al.

Ingår i International Journal of Cancer, s. 2254-2262, 2018

• DOI för Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study

Abstract GS5-08: A validation of DCIS biological risk profile in a randomised study for radiation therapy with 20 year follow-up (SweDCIS)

Wärnberg, Fredrik; Garmo, Hans; Folkvaljon, Yasin; Holmberg, Lars et al.

Ingår i Cancer Research, 2018

• DOI för Abstract GS5-08: A validation of DCIS biological risk profile in a randomised study for radiation therapy with 20 year follow-up (SweDCIS)

The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors

Eriksson, John; Garmo, Hans; Hellman, Per; Ihre-Lundgren, Catharina

Ingår i Annals of Surgical Oncology, s. 1214-1220, 2017

• DOI för The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors
• Ladda ner fulltext (pdf) av The Influence of Preoperative Symptoms on the Death of Patients with Small Intestinal Neuroendocrine Tumors

Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

Thomsen, Frederik Birkebæk; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela Franck et al.

Ingår i European Urology, s. 920-928, 2017

• DOI för Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study
• Ladda ner fulltext (pdf) av Gonadotropin-releasing Hormone Agonists, Orchiectomy, and Risk of Cardiovascular Disease: Semi-ecologic, Nationwide, Population-based Study

DCIS and the risk of breast cancer death - A case control study

Wadsten, C.; Garmo, Hans; Fredriksson, I.; Sund, M. et al.

Ingår i Cancer Research, 2017

• DOI för DCIS and the risk of breast cancer death - A case control study

Use of palliative medications before death from prostate cancer: a population based study

Lycken, Magdalena; Drevin, Linda; Garmo, Hans; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 25-26, 2017

• DOI för Use of palliative medications before death from prostate cancer: a population based study

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

Ghoshal, Arunangshu; Garmo, Hans; Arthur, Rhonda; Hammar, Niklas et al.

Ingår i ecancermedicalscience, 2017

• DOI för Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
• Ladda ner fulltext (pdf) av Serum biomarkers to predict risk of testicular and penile cancer in AMORIS

No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

Thomsen, Frederik B.; Sandin, Fredrik; Garmo, Hans; Lissbrant, Ingela F. et al.

Ingår i Scandinavian journal of urology, s. 16-16, 2017

• DOI för No difference in risk of cardiovascular disease in men with prostate cancer treated with GnRH agonists or orchiectomy: semi-ecologic, nationwide, population-based study

The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

Nderitu, Paul; Bosco, Cecilia; Garmo, Hans; Holmberg, Lars et al.

Ingår i International Journal of Cancer, s. 1148-1160, 2017

• DOI för The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort

LEUKEMIC TRANSFORMATION AND SECOND CANCERS IN 3649 HIGH RISK ET PATIENTS IN THE EXELS STUDY

Birgegård, Gunnar; Folkvaljon, Yasin; Garmo, Hans; Holmberg, Lars et al.

Ingår i Haematologica, s. 282-282, 2017

Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Van Hemelrijck, Mieke; Folkvaljon, Yasin; Adolfsson, Jan; Akre, Olof et al.

Ingår i BJU International, s. 507-514, 2016

• DOI för Causes of death in men with localized prostate cancer: a nationwide, population-based study.
• Ladda ner fulltext (pdf) av Causes of death in men with localized prostate cancer: a nationwide, population-based study.

Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Bratt, Ola; Drevin, Linda; Akre, Olof; Garmo, Hans et al.

Ingår i Journal of the National Cancer Institute, 2016

• DOI för Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study
• Ladda ner fulltext (pdf) av Family History and Probability of Prostate Cancer, Differentiated by Risk Category: A Nationwide Population-Based Study

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Crawley, Danielle; Garmo, Hans; Rudman, Sarah; Stattin, Pär et al.

Ingår i International Journal of Cancer, s. 2698-2704, 2016

• DOI för Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
• Ladda ner fulltext (pdf) av Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Van Hemelrijck, Mieke; Garmo, Hans; Wigertz, Annette; Nilsson, Per et al.

Ingår i International Journal of Epidemiology, s. 73-82, 2016

• DOI för Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base--a refined prostate cancer trajectory.

Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Häggström, Christel; Stattin, Pär; Stocks, Tanja; Garmo, Hans et al.

Ingår i BJU International, s. 850-852, 2016

• DOI för Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer
• Ladda ner fulltext (pdf) av Interpretation of conventional survival analysis and competing-risk analysis: an example of hypertension and prostate cancer

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Wulaningsih, Wahyu; Sagoo, Harkiran K.; Hamza, Mustafa; Melvin, Jennifer et al.

Ingår i International Journal of Molecular Sciences, 2016

• DOI för Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
• Ladda ner fulltext (pdf) av Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies

Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

O'Farrell, Sean; Garmo, Hans; Holmberg, Lars; Adolfsson, Jan et al.

Ingår i Journal of Clinical Oncology, s. 1243-1251, 2015

• DOI för Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

Lindhagen, Lars; Van Hemelrijck, Mieke; Robinson, David; Stattin, Pär et al.

Ingår i BMC Medical Informatics and Decision Making, 2015

• DOI för How to model temporal changes in comorbidity for cancer patients using prospective cohort data
• Ladda ner fulltext (pdf) av How to model temporal changes in comorbidity for cancer patients using prospective cohort data

5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Robinson, David; Garmo, Hans; Holmberg, Lars; Stattin, Pär

Ingår i Cancer Causes and Control, s. 1289-1297, 2015

• DOI för 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
• Ladda ner fulltext (pdf) av 5-alpha reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer

Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Wulaningsih, Wahyu; Holmberg, Lars; Garmo, Hans; Malmstrom, Håkan et al.

Ingår i Carcinogenesis, s. 1121-1128, 2015

• DOI för Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

Robinson, David; Garmo, Hans; Stattin, Pär; Michaëlsson, Karl

Ingår i PLOS ONE, 2015

• DOI för Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
• Ladda ner fulltext (pdf) av Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study

An investigation into the relationship between Statins and Cancer using population-based data

Melvin, Jennifer C; Garmo, Hans; Daniel, Rhian; Shanmugalingam, Thurkaa et al.

Ingår i BJU International, s. 681-683, 2015

• DOI för An investigation into the relationship between Statins and Cancer using population-based data

Anabolic steroids and cardiovascular risk: A national population-based cohort study

Thiblin, Ingemar; Garmo, Hans; Garle, Mats; Holmberg, Lars et al.

Ingår i Drug And Alcohol Dependence, s. 87-92, 2015

• DOI för Anabolic steroids and cardiovascular risk: A national population-based cohort study

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Wulaningsih, Wahyu; Vahdaninia, Mariam; Rowley, Mark; Holmberg, Lars et al.

Ingår i BMC Cancer, 2015

• DOI för Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
• Ladda ner fulltext (pdf) av Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans; Rider, Jennifer R. et al.

Ingår i New England Journal of Medicine, s. 932-942, 2014

• DOI för Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

Drug Prescription for Erectile Dysfunction Before and After Diagnosis of Localized Prostate Cancer

Plym, Anna; Folkvaljon, Yasin; Garmo, Hans; Holmberg, Lars et al.

Ingår i Journal of Sexual Medicine, s. 2100-2108, 2014

• DOI för Drug Prescription for Erectile Dysfunction Before and After Diagnosis of Localized Prostate Cancer

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Rosmarin, Dan; Palles, Claire; Church, David; Domingo, Enric et al.

Ingår i Journal of Clinical Oncology, s. 1031-1039, 2014

• DOI för Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy

Lundstrom, Karl-Johan; Drevin, Linda; Carlsson, Stefan; Garmo, Hans et al.

Ingår i Journal of Urology, s. 1116-1122, 2014

• DOI för Nationwide Population Based Study of Infections after Transrectal Ultrasound Guided Prostate Biopsy

Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men

Ax, Erika; Garmo, Hans; Grundmark, Birgitta; Bill-Axelson, Anna et al.

Ingår i Nutrition and Cancer, s. 77-87, 2014

• DOI för Dietary Patterns and Prostate Cancer Risk: Report from the Population Based ULSAM Cohort Study of Swedish Men

Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial

Wärnberg, Fredrik; Garmo, Hans; Emdin, Stefan; Hedberg, Veronica et al.

Ingår i Journal of Clinical Oncology, s. 3613-3618, 2014

• DOI för Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial

Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins

Michaëlsson, Karl; Nordström, Peter; Nordström, Anna; Garmo, Hans et al.

Ingår i Journal of Bone and Mineral Research, s. 424-431, 2014

• DOI för Impact of hip fracture on mortality: a cohort study in hip fracture discordant identical twins

Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study

Lycken, Magdalena; Garmo, Hans; Adolfsson, Jan; Stattin, Par et al.

Ingår i European Journal of Cancer, s. 1789-1798, 2014

• DOI för Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: A population-based study

Breast cancer in young women - age a risk factor only in those not given chemotherapy

Fredholm, H.; Magnusson, Kristina; Lindstrom, L. S.; Garmo, Hans et al.

Ingår i The Breast, 2014

• DOI för Breast cancer in young women - age a risk factor only in those not given chemotherapy

Iron metabolism and risk of cancer in the Swedish AMORIS study

Gaur, Anjali; Collins, Helen; Wulaningsih, Wahyu; Holmberg, Lars et al.

Ingår i Cancer Causes and Control, s. 1393-1402, 2013

• DOI för Iron metabolism and risk of cancer in the Swedish AMORIS study
• Ladda ner fulltext (pdf) av Iron metabolism and risk of cancer in the Swedish AMORIS study

Fatherhood status and risk of prostate cancer: Nationwide, population-based case-control study

Wiren, Sara M.; Drevin, Linda I.; Carlsson, Sigrid V.; Akre, Olof et al.

Ingår i International Journal of Cancer, s. 937-943, 2013

• DOI för Fatherhood status and risk of prostate cancer: Nationwide, population-based case-control study

The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

van Hemelrijck, Mieke; Garmo, Hans; Hammar, Niklas; Jungner, Ingmar et al.

Ingår i International Journal of Cancer, s. 2118-2128, 2013

• DOI för The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study

Population-based study on use of chemotherapy in men with castration resistant prostate cancer

Lissbrant, Ingela Franck; Garmo, Hans; Widmark, Anders; Stattin, Par

Ingår i Acta Oncologica, s. 1593-1601, 2013

• DOI för Population-based study on use of chemotherapy in men with castration resistant prostate cancer

Dietary Patterns and prostate cancer risk: a population based cohort study in elderly Swedish men

Ax, Erika Helena; Cederholm, Tommy; Grundmark, Birgitta; Bill-Axelson, Anna et al.

Ingår i The FASEB Journal, s. 847.8, 2013

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Wulaningsih, Wahyu; Michaelsson, Karl; Garmo, Hans; Hammar, Niklas et al.

Ingår i BMC Public Health, s. 663, 2013

• DOI för Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
• Ladda ner fulltext (pdf) av Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

Van Hemelrijck, Mieke; Wigertz, Annette; Sandin, Fredrik; Garmo, Hans et al.

Ingår i International Journal of Epidemiology, s. 956-967, 2013

• DOI för Cohort Profile: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base Sweden 2.0

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Wulaningsih, Wahyu; Michaelsson, Karl; Garmo, Hans; Hammar, Niklas et al.

Ingår i BMC Cancer, 2013

• DOI för Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
• Ladda ner fulltext (pdf) av Inorganic phosphate and the risk of cancer in the Swedish AMORIS study

Mortality following Hip Fracture in Men with Prostate Cancer

van Hemelrijck, Mieke; Garmo, Hans; Michaëlsson, Karl; Thorstenson, Andreas et al.

Ingår i PLOS ONE, 2013

• DOI för Mortality following Hip Fracture in Men with Prostate Cancer
• Ladda ner fulltext (pdf) av Mortality following Hip Fracture in Men with Prostate Cancer

Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

Bill-Axelson, Anna; Garmo, Hans; Holmberg, Lars; Johansson, Jan-Erik et al.

Ingår i European Urology, s. 920-928, 2013

• DOI för Long-term Distress After Radical Prostatectomy Versus Watchful Waiting in Prostate Cancer: A Longitudinal Study from the Scandinavian Prostate Cancer Group-4 Randomized Clinical Trial

Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

Robinson, David; Garmo, Hans; Bill-Axelson, Anna; Mucci, Lorelei et al.

Ingår i The BMJ, 2013

• DOI för Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
• Ladda ner fulltext (pdf) av Use of 5 alpha-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study

Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma

Moller, Henrik; Purushotham, Arnie; Linklater, Karen M.; Garmo, Hans et al.

Ingår i European Journal of Cancer, s. 3686-3693, 2013

• DOI för Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma
• Ladda ner fulltext (pdf) av Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma

Gamma-glutamyl transferase and c-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: A prospective cohort study

Melvin, J. C.; Rodrigues, C.; Holmberg, Lars; Garmo, Hans et al.

Ingår i International Journal of Molecular Epidemiology and Genetics, s. 276-285, 2012

Biomarker-based score to predict mortality in persons aged 50 years and older: a new approach in the Swedish AMORIS study

van Hemelrijck, Mieke; Harari, Danielle; Garmo, Hans; Hammar, Niklas et al.

Ingår i International Journal of Molecular Epidemiology and Genetics, s. 66-76, 2012

Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study

Vichapat, Voralak; Garmo, Hans; Holmqvist, Marit; Liljegren, Göran et al.

Ingår i Journal of Clinical Oncology, s. 3478-3485, 2012

• DOI för Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study

Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study

Seth, Divya; Garmo, Hans; Wigertz, Annette; Holmberg, Lars et al.

Ingår i International Journal of Molecular Epidemiology and Genetics, s. 122-133, 2012

Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

van Hemelrijck, Mieke; Garmo, Hans; Holmberg, Lars; Stattin, Pär et al.

Ingår i European Urology, s. 690-700, 2012

• DOI för Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden

Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men

Berglund, Lars; Berne, Christian; Svärdsudd, Kurt; Garmo, Hans et al.

Ingår i Upsala Journal of Medical Sciences, s. 35-40, 2012

• DOI för Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly men

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Wulaningsih, Wahyu; Garmo, Hans; Holmberg, Lars; Hammar, Niklas et al.

Ingår i Journal of Cancer Epidemiology, s. 792034, 2012

• DOI för Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
• Ladda ner fulltext (pdf) av Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer

Nilsson, Greger; Holmberg, Lars; Garmo, Hans; Duvernoy, Olov et al.

Ingår i Journal of Clinical Oncology, s. 380-386, 2012

• DOI för Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer

Patterns of metastasis in women with metachronous contralateral breast cancer

Vichapat, V.; Garmo, Hans; Holmberg, Lars; Fentiman, I. S. et al.

Ingår i British Journal of Cancer, s. 221-223, 2012

• DOI för Patterns of metastasis in women with metachronous contralateral breast cancer

Anti-androgen prescribing patterns, patient treatment adherence and influencing factors: results from the nationwide PCBaSe Sweden

Grundmark, Birgitta; Garmo, Hans; Zethelius, Björn; Stattin, P et al.

Ingår i European Journal of Clinical Pharmacology, s. 1619-1630, 2012

• DOI för Anti-androgen prescribing patterns, patient treatment adherence and influencing factors: results from the nationwide PCBaSe Sweden

Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Van Hemelrijck, Mieke; Hermans, Ruben; Michaëlsson, Karl; Melvin, Jennifer et al.

Ingår i Cancer Causes and Control, s. 1349-1358, 2012

• DOI för Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study

Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

Lambe, Mats; Wigertz, Annette; Garmo, Hans; Walldius, Göran et al.

Ingår i Cancer Causes and Control, s. 1163-1171, 2011

• DOI för Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer

Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up

Grundmark, Birgitta; Zethelius, Björn; Garmo, Hans; Holmberg, Lars

Ingår i BMC Cancer, s. 431, 2011

• DOI för Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up
• Ladda ner fulltext (pdf) av Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up

Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden

Akre, Olof; Garmo, Hans; Adolfsson, Jan; Lambe, Mats et al.

Ingår i European Urology, s. 554-563, 2011

• DOI för Mortality Among Men with Locally Advanced Prostate Cancer Managed with Noncurative Intent: A Nationwide Study in PCBaSe Sweden

The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

Grundmark, Birgitta; Garmo, Hans; Loda, Massimo; Busch, Christer et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 2088-2096, 2010

• DOI för The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes

Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative

Carlhed, Rickard; Bojestig, Mats; Peterson, Anette; Åberg, Christina et al.

Ingår i Circulation. Cardiovascular quality and outcomes, s. 458-464, 2009

• DOI för Improved clinical outcome after acute myocardial infarction in hospitals participating in a Swedish quality improvement initiative

Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements

Berglund, Lars; Garmo, Hans; Lindbäck, Johan; Svärdsudd, Kurt et al.

Ingår i Statistics in Medicine, s. 4397-4407, 2008

• DOI för Maximum likelihood estimation of correction for dilution bias in simple linear regression using replicates from subjects with extreme first measurements

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Glimelius, Bengt; Sørbye, H; Balteskard, L; Byström, P et al.

Ingår i Annals of Oncology, s. 909-914, 2008

• DOI för A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Increased incidence of stroke in women with breast cancer

Nilsson, Greger; Holmberg, Lars; Garmo, Hans; Terent, Andreas et al.

Ingår i European Journal of Cancer, s. 423-429, 2005

• DOI för Increased incidence of stroke in women with breast cancer

TFF3 in primary tumours has a negative impact on survival in small intestinal neuroendocrine tumours

Eriksson, John; Juhlin, Christofer; Backman, Samuel; Edfeldt, Katarina et al.

Primary small intestinal tumours are highly prevalent and often multiple before metastatic disease develops

Eriksson, John; Norlén, Olov; Ögren, Mats; Garmo, Hans et al.

Prognostic factors for death after surgery for small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, Catharina; Hellman, Per

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Beckmann, Kerri; Garmo, Hans; Franck Lissbrant, Ingela; Stattin, Pär

Ingår i Cancers, 2021

• DOI för The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
• Ladda ner fulltext (pdf) av The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries

Random railways modelled as random 3-regular graphs

Garmo, Hans

1995

Symptomatic disease at the time of surgery have prognostic impact in small intestinal neuroendocrine tumours

Eriksson, John; Garmo, Hans; Ihre-Lundgren, Catharina; Hellman, Per

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.